Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08RZV
|
||||
Former ID |
DIB012931
|
||||
Drug Name |
HSR-609
|
||||
Synonyms |
FY-609; 3-[4-(8-Fluoro-5,11-dihydrobenz[b]oxepino[4,3-b]pyridin-11-ylidene)piperidin-1-yl]propionic acid dihydrate
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Rhinitis [ICD9: 472.0, 477; ICD10:J00, J30, J31.0] | Discontinued in Phase 2 | [545924] | ||
Structure |
Download2D MOL |
||||
Formula |
C21H25FN2O5
|
||||
Canonical SMILES |
C1CN(CCC1=C2C3=C(C=C(C=C3)F)OCC4=C2N=CC=C4)CCC(=O)O.O.O
|
||||
InChI |
1S/C21H21FN2O3.2H2O/c22-16-3-4-17-18(12-16)27-13-15-2-1-8-23-21(15)20(17)14-5-9-24(10-6-14)11-7-19(25)26;;/h1-4,8,12H,5-7,9-11,13H2,(H,25,26);2*1H2
|
||||
InChIKey |
CWNCDQYLHMXURI-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 153250-51-2
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Histamine H1 receptor | Target Info | Antagonist | [534391], [551871] | |
PANTHER Pathway | Histamine H1 receptor mediated signaling pathway | ||||
References | |||||
Ref 534391 | Studies on the novel antiallergic agent HSR-609: its penetration into the central nervous system in mice and guinea pigs and its selectivity for the histamine H1-receptor. Jpn J Pharmacol. 1997 Apr;73(4):291-8. | ||||
Ref 551871 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.